GlaxoSmithKline

GSK
Real-time CHI-X EUROPE LIMITED. - 02/25 04:38:00 am
1627.2GBp
-0.05%
Prev.1629.8000
Open1627.0000
High1634.2000
Low1622.2000
Volume801 974
Financials
Sales 2020 34 843 M
EBIT 2020 9 123 M
Net income 2020 4 300 M
Debt 2020 23 712 M
Yield 2020 4,91%
P/E ratio 2020 19,2x
P/E ratio 2021 18,6x
EV / Sales2020 3,01x
EV / Sales2021 2,86x
Capitalization 81 108 M
Company
GlaxoSmithkline is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (56%): intended for respiratory diseases (40.1% of net sales), HIV infection (27.3%), immune system disorders (2.7%) ) and other (29,8%);
- OTC and...
Sector :
Pharmaceuticals - NEC
Calendar :
2020-03-24 Presentation
Trading Rating :
Investor Rating :
Latest news
02/24MEDIVIR PUBL : and Shijiazhuang Yuanmai Biotechnology sign licensing agreement regarding manufacturing and sales of XerclearŽ in China
AQ
02/24GLAXOSMITHKLINE : Says FDA Accepts SNDA Application for Zejula
DJ
02/24STADA ARZNEIMITTEL : Correction to Stada Acquisition Story
DJ
02/24STADA ARZNEIMITTEL : Germany's Stada Buys 15 Consumer Brands From GlaxoSmithKLine
DJ
02/24EXCLUSIVE : Germany's Stada buys 15 GSK consumer health brands
RE
02/24GLAXOSMITHKLINE : China's Clover in research venture with GSK on coronavirus vaccine candidate
RE
02/24GLAXOSMITHKLINE : China's Clover in research venture with GSK on coronavirus vaccine candidate
RE
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance1 7621 8461 846
Spread/Res.-7,6%-12%-12%
Spread/Supp.0,02%0,02%8,4%
Support1 6271 6271 502